Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Arthralgia × Aromatase Inhibitors × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 2 Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 55 Polycystic Ovary Syndrome 3 Neoplasms, Hormone-Dependent 3 Neoplasm Metastasis 2 Carcinoma, Lobular 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Ductal, Breast 2 Breast Cancer Female 2 Advanced Breast Cancer 2 Sexuality 1 Osteoporosis 1 Luminal B/HER2-negative Breast Cancer 1 Leiomyoma 1 Infertility 1 Hormone Receptor Positive Breast Carcinoma 1 Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1 Fractures, Bone 1 Estrogen Receptor and/or Progesterone Receptor Positive 1 Endometrial Neoplasms 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Neoplasms, Male 1 Breast Diseases 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Bone Diseases, Metabolic 1 Arthralgia 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Surveys and Questionnaires 3 Testosterone 2 Fatty Acids, Omega-3 2 Exercise 2 Acupuncture Therapy 2 methyl hydroxyethyl cellulose 1 guizhi-shaoyao-zhimu decoction 1 canakinumab 1 Yoga 1 Walking 1 Vitamin B 12 1 Therapeutics 1 Occupational Therapy 1 Letrozole 1 Hyaluronic Acid 1 Glucosamine 1 Glucaric Acid 1 Gabapentin 1 Fish Oils 1 Educational Status 1 Docosahexaenoic Acids 1 Diphosphonates 1 Diet Therapy 1 Denosumab 1 Curcumin 1 Chondroitin Sulfates 1 Chondroitin 1 Cholecalciferol 1 Cannabidiol 1 Calcium Gluconate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01612728 2013-02-12

AIA

Baylor Breast Care Center

Phase 2 Withdrawn

Breast Neoplasms, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡